Higher reimbursement, regulatory clarity, and acknowledgment of future indication expansion expected to reinforce physician confidence and support continued expansion ...

CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and ...

The Centers for Medicare & Medicaid Services (CMS) on Friday finalized its annual physician fee schedule for 2026, giving ...

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...

Bellevue-based AlethianAI has emerged from stealth, unveiling what it calls the first agentic AI healthcare delivery platform ...

2025 Financial Guidance Sight Sciences raises its revenue guidance expectations for full year 2025 to $76.0 million to $78.0 million, representing a 2% to 5% decline compared to full year 2024 revenue ...

Two new studies being presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and ...

Empowering early detection of the high-risk plaque attack.” Medicare now covers AI-enabled coronary plaque analysis from CCTA with a Category III CPT code, 0625T, and national payment set at $950 ...

ASBISc Enterprises Plc, a Cyprus-based distributor of ICT and IoT products across Europe, the Middle East, and Africa, ...

Inspire Medical Systems (INSP) has posted standout numbers once again, with revenue on track to climb 10.7% annually and earnings projected to surge 25.6% per year over the next three years, both ...

At this time, I would like to welcome everyone to the Inspire Medical Systems Third Quarter 2025 Conference Call. [Operator Instructions] I'll now hand the call over to your first speaker, Ezgi Yagci, ...

The following information was released by the Ohio State Medical Association:. There has been a huge amount of legislative activity over the past two weeks on OSMA-supported insurance reform proposals ...